Zobrazeno 1 - 10
of 231
pro vyhledávání: '"Yoshihiro Endo"'
Autor:
Masanori Abe, Hidetoshi Shiga, Hiroomi Tatsumi, Yoshihiro Endo, Yoshihiko Kikuchi, Yasushi Suzuki, Kent Doi, Taka-Aki Nakada, Hiroyuki Nagafuchi, Noriyuki Hattori, Nobuyuki Hirohashi, Takeshi Moriguchi, Osamu Yamaga, Osamu Nishida
Publikováno v:
Renal Replacement Therapy, Vol 8, Iss 1, Pp 1-11 (2022)
Abstract Background The Japan Society for Blood Purification in Critical Care (JSBPCC) has reported survey results on blood purification therapy (BPT) for critically ill patients in 2005, 2009, and 2013. To clarify the current clinical status, includ
Externí odkaz:
https://doaj.org/article/c9b6fc92bd664822b133c03d49959a12
Autor:
Kanako Kojima, Sanai Takahashi, Shungo Saito, Yoshihiro Endo, Tadashi Nittami, Tadashige Nozaki, Ranbir Chander Sobti, Masatoshi Watanabe
Publikováno v:
Applied Sciences, Vol 8, Iss 1, p 134 (2018)
Patients with metastatic castration-resistant prostate cancer (mCRPC) have poor outcomes. Docetaxel (DTX)-based therapy is a current standard treatment for patients with mCRPC. Approaches combining conventional chemotherapeutic agents and nanoparticl
Externí odkaz:
https://doaj.org/article/9bc01c3782e34a6cac2a362032796c83
Autor:
Katsushi Takebayashi, Eiji Mekata, Hiromichi Sonoda, Tomoharu Shimizu, Hisanori Shiomi, Shigeyuki Naka, Yoshihiro Endo, Tohru Tani
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e73215 (2013)
PURPOSE: We retrospectively evaluated the in vitro chemosensitivity of primary site and metastatic site tumors in colorectal cancer. METHODS: Various resected tumor samples (33 from lymph nodes, 42 from liver, six from lung, and 68 primary tumors) we
Externí odkaz:
https://doaj.org/article/74a7d1e65cf84e85843da861432db5a6
Autor:
Hiroshi Yamamoto, Kazuhisa Maeda, Yoshitaka Uji, Hiroshi Tsuchihashi, Tsuyoshi Mori, Tomoharu Shimizu, Yoshihiro Endo, Aya Kadota, Katsuyuki Miura, Yusuke Koga, Toshinori Ito, Tohru Tani
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e56129 (2013)
BACKGROUND AND PURPOSE: Infections are important causes of postoperative morbidity after gastric surgery; currently, no factors have been identified that can predict postoperative infection. Adiponectin (ADN) mediates energy metabolism and functions
Externí odkaz:
https://doaj.org/article/1884f9ef1ab84b618fa9fe1043c88349
Publikováno v:
SPIE Future Sensing Technologies 2023.
Autor:
Yusuke Inoue, Shunichi Yanai, Kazutaka Kukita, Yoshihiro Endo, Kazuya Kitamura, Keisuke Kawasaki, Izumi Hasegawa, Motoki Yonekawa, Ken Kawakami, Masaki Katagiri, Hiroki Nakamura, Kazuhito Kani, Takayuki Matsumoto, Shingo Kato, Tomonari Ogawa, Takuya Doi, Kazuhide Higuchi, Kazuki Kakimoto
Publikováno v:
Therapeutic Apheresis and Dialysis
Several adsorptive type devices for ulcerative colitis are used for the induction of remission in patients with active severe disease worldwide. In 2020, the novel apheresis device Immunopure for ulcerative colitis was launched in Japan. Immunopure,
Autor:
Tomoyuki Ueki, Masatsugu Kojima, Yoshihiro Endo, Hiroyuki Ohta, Toru Miyake, Tsuyoshi Yamaguchi, Masaji Tani, Eiji Mekata, Tomoharu Shimizu, Sachiko Kaida, Hiroya Iida
Publikováno v:
Digestive Surgery. 38:80-86
Background:Procalcitonin (PCT) is a well-known marker for bacterial infection; however, the clinical significance of PCT in the long-term prognosis after colorectal cancer (CRC) surgery remains unclear.
Methods:This is a retrospective review of
Methods:This is a retrospective review of
Autor:
Yoshihiro Endo
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 24(2):104-107
Autor:
Takaya Abe, Hidenori Matsuo, Ryuzo Abe, Shinji Abe, Hiroaki Asada, Akira Ashida, Akiyasu Baba, Kei Eguchi, Yutaka Eguchi, Yoshihiro Endo, Yoshihiro Fujimori, Kengo Furuichi, Yutaka Furukawa, Mayumi Furuya, Tomoki Furuya, Norio Hanafusa, Wataru Hara, Mariko Harada‐Shiba, Midori Hasegawa, Noriyuki Hattori, Motoshi Hattori, Sumi Hidaka, Toshihiko Hidaka, Chika Hirayama, Shigaku Ikeda, Hideaki Imamura, Kazuaki Inoue, Keita Ishizuka, Kiyonobu Ishizuka, Takafumi Ito, Hitomi Iwamoto, Syoko Izaki, Maki Kagitani, Shuzo Kaneko, Naoto Kaneko, Takuro Kanekura, Kiyoki Kitagawa, Makio Kusaoi, Youwei Lin, Takeshi Maeda, Hisashi Makino, Shigeki Makino, Kenichi Matsuda, Takao Matsugane, Yusuke Minematsu, Michio Mineshima, Kenichiro Miura, Katsuichi Miyamoto, Takeshi Moriguchi, Mayumi Murata, Makoto Naganuma, Hajime Nakae, Shinya Narukawa, Atsushi Nohara, Kyoichi Nomura, Hirofumi Ochi, Atsushi Ohkubo, Takayasu Ohtake, Kazuya Okada, Tomokazu Okado, Yoshiki Okuyama, Susumu Omokawa, Satoru Oji, Norihiko Sakai, Yuichiro Sakamoto, Shigeru Sasaki, Motoyoshi Sato, Mariko Seishima, Hidetoshi Shiga, Homare Shimohata, Noriko Sugawara, Kohei Sugimoto, Yasushi Suzuki, Masato Suzuki, Takashi Tajima, Yasuhiro Takikawa, Satoru Tanaka, Kenjiro Taniguchi, Satoko Tsuchida, Tatsuo Tsukamoto, Kenji Tsushima, Yasunori Ueda, Takashi Wada, Hiromichi Yamada, Hiroyuki Yamada, Toshihiko Yamaka, Ken'ichiro Yamamoto, Yoko Yokoyama, Norihito Yoshida, Toyokazu Yoshioka, Ken Yamaji
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyREFERENCE. 25(6)
Most of the diseases for which apheresis therapy is indicated are intractable and rare, and each patient has a different background and treatment course prior to apheresis therapy initiation. Therefore, it is difficult to conduct large-scale randomiz
Publikováno v:
Surgery. 169(4)
Background:Mechanisms underlying hemodynamic disturbance in hemorrhagic shock are not completely understood. Transient receptor potential vanilloid 1-expressing afferents are involved in hemorrhagic shock pathology, and transient receptor potential v